About this trial
A growing body of evidence suggests patients with late-onset seizures are at an increased risk of stroke, but the potential for reducing cardiovascular morbidity through risk factor screening and management is unknown.
The investigators aim to determine whether individuals with new-onset unprovoked seizures after middle age should undergo vascular risk assessment. In a cluster project the investigators assess the effect of vascular risk factor screening in an observational study as well as a cohort study.
The project has two interlinked components: a prospective single group study, in which risk factor assessment is performed and subsequent management is followed for one year; and a register-based cohort study examining the long-term effects of the intervention on a system level.
Eligibility criteria
Qualifiers
age ≥50 with a first-ever outpatient appointment to one of the participating clinics and
a first-listed diagnostic code for seizures or epilepsy (ICD-10: R568, G40)
Disqualifiers
Inability to consent.
Progressive brain disease (tumour or degenerative)
preexisting seizures/epilepsy, as demonstrated by a registered diagnostic code for seizures (ICD-10: R568, G40, G41) or a dispensed antiseizure medication (ATC-code: N03) more than 3 months before the initial consultation
a registered diagnostic code for stroke or TIA (ICD-10: I61, I63, I64, or G45 except G454) before the initial consultation, or
Trial design
Treatments tested in this trial
- Vascuar risk factor screening (blood pressure, medical history, BMI, laboratory tests)
Treatment groups
Sponsors and collaborators
Sahlgrenska University Hospital
Lead sponsor
Sodra Alvsborgs Hospital
Collaborator
Skane University Hospital
Collaborator
Danderyd Hospital
Collaborator
Uppsala University Hospital
Collaborator